2. Home
  3. Video Lectures
  4. CRPC w/ Bone Metastases

CRPC with Bone Metastases Video Lectures

CRPC w/ Bone Metastases
Imaging Modality and Recommendations Included in RADAR 3: Interview with Phillip Koo
June 4, 2018
Details
CRPC w/ Bone Metastases
Whole Body MRI Scanning and Disease Progression - Anwar Padhani
December 14, 2017
Details
CRPC w/ Bone Metastases
The Future of Targeted Alpha Therapy - Neal Shore
December 10, 2017
Details
CRPC w/ Bone Metastases
RADAR II Group Recommendations - The Role of Therapeutic Layering
November 24, 2017
Details
CRPC w/ Bone Metastases
Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster
August 21, 2017
Details
CRPC w/ Bone Metastases
Radium-223: From Bench to Bed-side, and the Future Directions for Targeted Alpha Therapy - Joe O'Sullivan
July 21, 2017
Details
CRPC w/ Bone Metastases
Therapeutic Layering in Optimizing Treatment for Patients With CPRC (RADAR II)- Phillip Koo
May 23, 2017
Details
CRPC w/ Bone Metastases
Use of Radium-223 in Clinical Practice: a Radiation Oncologist's Experience - Daniel Spratt
November 8, 2016
Details
CRPC w/ Bone Metastases
Operationalization of Radium-223 Therapy for Bone Metastases - Eric Rohren
October 17, 2016
Details
CRPC w/ Bone Metastases
Eric Rohren on Radium-223 Therapy for Bone Metastases - State of the Art Lecture
August 2, 2016
Details
CRPC w/ Bone Metastases
Abiraterone Acetate and Radium-223 in Castrate-Resistant Prostate Cancer: Finding the Right Treatment at the Right Time - Charles Ryan
July 28, 2016
Details
CRPC w/ Bone Metastases
Cristina Nanni on Flucicovine F18 (FACBC) in Prostate Cancer - State of the Art Presentation
July 13, 2016
Details
CRPC w/ Bone Metastases
eRADicAte: A Study of Radium-223 with Abiraterone Acetate in Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases - Neal Shore
June 28, 2016
Details
CRPC w/ Bone Metastases
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo
June 21, 2016
Details
CRPC w/ Bone Metastases
Detection of Metastatic Disease in Prostate Cancer: Past, Present, Future- Phillip Koo
April 21, 2016
Details
CRPC w/ Bone Metastases
Radiopharmaceuticals in Prostate Cancer - Stefano Fanti
April 1, 2016
Details
CRPC w/ Bone Metastases
Radium-223: Nuclear Medicine Perspective - Phillip Koo
February 12, 2016
Details
CRPC w/ Bone Metastases
Detection of Metastatic Disease: Review of the RADAR Group Recommendations - Phillip Koo
February 2, 2016
Details
CRPC w/ Bone Metastases
Radium-223 in an International Early Access Program (EAP): Effects of Concomitant Medication on Overall Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
January 18, 2016
Details
CRPC w/ Bone Metastases
Effects of concomitant use of abiraterone and/or enzalutamide with radium-223
October 2, 2015
Details
CRPC w/ Bone Metastases
Radium-223 For mCRPC: The Urologist Perspective - Neal Shore
September 7, 2015
Details
CRPC w/ Bone Metastases
The Art and Science of Treating CRPC with Bone Metastases - Charles Ryan
September 8, 2015
Details
CRPC w/ Bone Metastases
Radium-223 in an Early Access Program: Effects of Concomitant Medication on OS in mCRPC Patients - Thomas Keane
June 15, 2015
Details
CRPC w/ Bone Metastases
EBRT Use and Safety with Radium-223 in Patients with CRPC and Bone Metastases from ALSYMPCA - Oliver Sartor
April 13, 2015
Details
CRPC w/ Bone Metastases
Radium-223 Expanded Access Program with Abiraterone and Enzalutamide - Oliver Sartor
April 10, 2015
Details
CRPC w/ Bone Metastases
Effects of Ra-223 with Docetaxel vs. Docetaxel on PSA and Bone Alkaline Phosphatase - Charles Ryan
March 16, 2015
Details
CRPC w/ Bone Metastases
Use of Radium-223 for Symptomatic mCRPC with or without Prior Docetaxel - Oliver Sartor
November 14, 2014
Details
CRPC w/ Bone Metastases
Lower Tumor Burden Patient with Progression after Sipuleucel-T, then Treated with Radium-223
October 10, 2014
Details
CRPC w/ Bone Metastases
Radium-223 added to Abiraterone Acetate Treatment
October 1, 2014
Details
CRPC w/ Bone Metastases
mCRPC: Assessing Progression from Asymptomatic to Symptomatic Disease
September 30, 2014
Details
CRPC w/ Bone Metastases
Impact of Prior Docetaxel, Extent of Disease, and Prior Bisphosphonates on Hematologic Safety of Ra-223
September 22, 2014
Details
CRPC w/ Bone Metastases
Utility of Radium-223 in Advanced Prostate Cancer
August 6, 2014
Details
CRPC w/ Bone Metastases
Practical Application of Ra-223: Treating mCRPC
June 17, 2014
Details
CRPC w/ Bone Metastases
Effect of Ra-223 on Symptomatic Skeletal Events in mCRPC
June 17, 2014
Details
CRPC w/ Bone Metastases
mCRPC Patient Shared Decision-making
June 16, 2014
Details
CRPC w/ Bone Metastases
Quantified Bone Scan Response After Radium-223
June 3, 2014
Details
CRPC w/ Bone Metastases
Bone-targeted Therapies and Radiopharmaceuticals
March 20, 2014
Details
CRPC w/ Bone Metastases
Height-Based Dosing with Ra-223
February 1, 2014
Details
CRPC w/ Bone Metastases
Radium-223 in mCRPC
December 9, 2013
Details